Finnrick, an independent testing programme, publishes 122 assays for SRY Labs: 79 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 43 did not. Most recent assay 20 Jul 2026.
SRY Labs listed by Finnrick as "Trading". Source: Finnrick, https://www.finnrick.com/vendors/sry-labs.
Finnrick-tested with poor results. Tested across 11 peptide products with 118 total samples.
SRY Labs is listed as active. Finnrick Grade D. Finnrick avg score: 6.4/10 across 118 samples (11 products). Below-average quality. Exercise caution.
SRY Labs holds independent lab grade D, assigned across 118 graded samples, average score 6.4/10. That grade comes from an independent grader's own sampling, not from PeptideAtlas, and it describes the samples that grader obtained rather than every batch sold.
| Product | Assays | Result |
|---|---|---|
| Tirzepatide | 36 | 34 passed, 2 failed |
| Retatrutide | 31 | 29 passed, 2 failed |
| Tesamorelin | 12 | 2 passed, 10 failed |
| Cagrilintide | 8 | 3 passed, 5 failed |
| TB-500 | 8 | 3 passed, 5 failed |
| BPC-157 | 7 | 2 passed, 5 failed |
| GHK-Cu | 7 | 2 passed, 5 failed |
| CJC-1295 | 4 | 1 passed, 3 failed |
| Semaglutide | 4 | 2 passed, 2 failed |
| Sermorelin | 3 | 1 passed, 2 failed |
| PT-141 | 2 | 0 passed, 2 failed |
Source: Finnrick, as published 2026-08-09. Pass and fail are Finnrick's classification against its own threshold, not ours.
| Status | Active |
|---|---|
| Independent lab grade | D (118 samples) |
| Average grader score | 6.4/10 |
| Vendor type | Research-use supplier |
| Satisfaction | 0.4/5 |
|---|---|
| Delivery | 4.5/5 |
| Customer service | 4.8/5 |
| Packaging | 4.8/5 |
| Ease of purchase | 4.7/5 |
| Payment | 4.7/5 |
Scored out of 5 by the same independent grader, from its own buyers rather than from this site.
These details were read from SRY Labs's own website on 2026-08-10. Pages consulted:
SRY Labs is listed as active and we hold 122 Finnrick assays (79 passing, 43 failing its purity threshold); an independent lab grade of D. That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
Yes. Finnrick, an independent testing programme, publishes 122 assays for SRY Labs: 79 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 43 did not. Most recent assay 20 Jul 2026.
Similar vendors: SwissChems, Bfflink, Reta-Peptide, HkRoids, Zenith Jove Peptide ZJ, Shanghai Baoju, Heman Peptide HM, Allen Biotechnology Co ABC.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Other reviewed vendors: SSR Bio Peptides Review, Steady Meds Peptides Review, Step One Ventures Peptides Review.